Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$33.72 - $48.22 $6.92 Million - $9.9 Million
-205,213 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$49.26 - $74.5 $5.09 Million - $7.69 Million
103,239 Added 101.24%
205,213 $11.2 Million
Q2 2021

Aug 13, 2021

BUY
$56.91 - $127.53 $5.8 Million - $13 Million
101,974 New
101,974 $7.49 Million

Others Institutions Holding CVAC

About CureVac N.V.


  • Ticker CVAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 187,467,008
  • Market Cap $538M
  • Description
  • CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...
More about CVAC
Track This Portfolio

Track Coatue Management LLC Portfolio

Follow Coatue Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coatue Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Coatue Management LLC with notifications on news.